164 related articles for article (PubMed ID: 31218465)
21. In vitro neurosphere formation correlates with poor survival in glioma.
C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
[TBL] [Abstract][Full Text] [Related]
22. Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.
De Vleeschouwer S; Ardon H; Van Calenbergh F; Sciot R; Wilms G; van Loon J; Goffin J; Van Gool S
Cancer Immunol Immunother; 2012 Nov; 61(11):2105-12. PubMed ID: 22565485
[TBL] [Abstract][Full Text] [Related]
23. Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ; Bindra RS; Contessa JN; Patel KR
Anticancer Res; 2019 Jun; 39(6):2911-2918. PubMed ID: 31177129
[TBL] [Abstract][Full Text] [Related]
24. Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study.
Upadhyaya SA; Ghazwani Y; Wu S; Broniscer A; Boop FA; Gajjar A; Qaddoumi I
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28708330
[TBL] [Abstract][Full Text] [Related]
25. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of FBXO17 gene expression in high-grade glioma.
Du D; Yuan J; Ma W; Ning J; Weinstein JN; Yuan X; Fuller GN; Liu Y
BMC Cancer; 2018 Jul; 18(1):773. PubMed ID: 30064493
[TBL] [Abstract][Full Text] [Related]
27. WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial.
Varlet P; Le Teuff G; Le Deley MC; Giangaspero F; Haberler C; Jacques TS; Figarella-Branger D; Pietsch T; Andreiuolo F; Deroulers C; Jaspan T; Jones C; Grill J
Neuro Oncol; 2020 Jan; 22(1):116-127. PubMed ID: 31419298
[TBL] [Abstract][Full Text] [Related]
28. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
[TBL] [Abstract][Full Text] [Related]
29. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC
Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
[TBL] [Abstract][Full Text] [Related]
30. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
Lote K; Egeland T; Hager B; Stenwig B; Skullerud K; Berg-Johnsen J; Storm-Mathisen I; Hirschberg H
J Clin Oncol; 1997 Sep; 15(9):3129-40. PubMed ID: 9294476
[TBL] [Abstract][Full Text] [Related]
31. High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
Amayiri N; Tabori U; Campbell B; Bakry D; Aronson M; Durno C; Rakopoulos P; Malkin D; Qaddoumi I; Musharbash A; Swaidan M; Bouffet E; Hawkins C; Al-Hussaini M;
Int J Cancer; 2016 Jan; 138(2):380-5. PubMed ID: 26293621
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
33. The influence of different classification standards of age groups on prognosis in high-grade hemispheric glioma patients.
Chen JW; Zhou CF; Lin ZX
J Neurol Sci; 2015 Sep; 356(1-2):148-52. PubMed ID: 26143529
[TBL] [Abstract][Full Text] [Related]
34. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma.
Wu W; Lamborn KR; Buckner JC; Novotny PJ; Chang SM; O'Fallon JR; Jaeckle KA; Prados MD
Neuro Oncol; 2010 Feb; 12(2):164-72. PubMed ID: 20150383
[TBL] [Abstract][Full Text] [Related]
35. Thalamic high-grade gliomas in children: a distinct clinical subset?
Kramm CM; Butenhoff S; Rausche U; Warmuth-Metz M; Kortmann RD; Pietsch T; Gnekow A; Jorch N; Janssen G; Berthold F; Wolff JE
Neuro Oncol; 2011 Jun; 13(6):680-9. PubMed ID: 21636712
[TBL] [Abstract][Full Text] [Related]
36. Pediatric neuro-oncology survival disparities in California.
Cooney T; Fisher PG; Tao L; Clarke CA; Partap S
J Neurooncol; 2018 May; 138(1):83-97. PubMed ID: 29417400
[TBL] [Abstract][Full Text] [Related]
37. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article.
Chang EF; Clark A; Jensen RL; Bernstein M; Guha A; Carrabba G; Mukhopadhyay D; Kim W; Liau LM; Chang SM; Smith JS; Berger MS; McDermott MW
J Neurosurg; 2009 Aug; 111(2):203-10. PubMed ID: 19267536
[TBL] [Abstract][Full Text] [Related]
38. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
Benesch M; Wagner S; Berthold F; Wolff JE
J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999
[TBL] [Abstract][Full Text] [Related]
39. Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas.
Guram K; Smith M; Ginader T; Bodeker K; Pelland D; Pennington E; Buatti JM
Pract Radiat Oncol; 2019 Jan; 9(1):16-23. PubMed ID: 30195927
[TBL] [Abstract][Full Text] [Related]
40. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
